Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biogaia Adr Class B BIOGY

Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics... see more

Recent & Breaking News (PINL:BIOGY)

DTS Expands Play-Fi(TM) Ecosystem to Include Top ODM Manufacturers for Unmatched Production Support

Business Wire January 7, 2014

Simply Hired Releases January Employment Outlook Report

Business Wire January 7, 2014

StemGenex® Offers New Options to Diabetes Patients through Cutting-Edge Stem Cell Therapy

PR Newswire January 7, 2014

Specific Technologies Announces New Publication Demonstrating Rapid Detection and Simultaneous Identification of Blood Bacteria Known to Cause Sepsis

Business Wire January 7, 2014

Oncology Services International Announces Service Support Expansion

Marketwired January 7, 2014

Monster Introduces DNA Pro Wireless Over-Ear Stereo Headphones at CES 2014

Business Wire January 7, 2014

NeoGenomics is the First Laboratory to Offer Calreticulin (CALR) Mutation Testing for the Diagnosis and Classification of Myeloproliferative Neoplasms

PR Newswire January 7, 2014

DDC Veterinary, A Division of DDC (DNA Diagnostics Center), Introduces a Unique Pet Tracking System, PetProtect360º(TM)

PR Newswire January 7, 2014

Applied BioCode Licenses its Barcoded Magnetic Bead Technology to Genetic Analysis AS for Multiplex Molecular Diagnostic Testing of Microbial Imbalances in the GI Tract

Business Wire January 7, 2014

ABRAXANE® Plus gemcitabine Receives European Marketing Authorization for First-Line Treatment of Patients with Metastatic Pancreatic Cancer

Business Wire January 7, 2014

CytoSorbents Retains Merriman Capital as Capital Markets Advisor

Thomson Reuters ONE January 7, 2014

Boost Careers of Female Scientists: Make Sure Women Help Choose Meeting Speakers

PR Newswire January 7, 2014

Well-known Chinese Brand CoolPad Shows at 2014 CES Exhibition with Its Multiple 4G Products

PR Newswire January 7, 2014

Horizon Discovery Announces Oncology Research, Collaboration and License Agreement with AstraZeneca

Business Wire January 7, 2014

Professor Inkeri Elomaa Receives the Pohjola and Suomi Mutual Medical Award

Thomson Reuters ONE January 7, 2014

Cell Medica Announces Orphan Drug Designation in the European Union for Cytovir ADV

Business Wire January 7, 2014

radioACTIVE inc. Releases "Sectional Walker", an Interactive CT and MRI Cross-Sectional Atlas in Head, Chest, Abdomen and Pelvis for iPad, iPhone and iPod touch Users

Business Wire January 7, 2014

AMD and BlueStacks Collaboration Brings Full Android OS Experience to Windows PCs

Marketwired January 6, 2014

CES Sets the Stage for MakerBot Launch of Expanded MakerBot 3D Printing Platform and Ecosystem with a Whole New Generation of 3D Printers and 3D Content

PR Newswire January 6, 2014

Paulson Capital Corp. Announces Shares to Resume Trading Pending Hearing Disposition; Issuance of and Intention to Appeal NASDAQ Determination Letter; and Appointment of Independent Director

Globe Newswire January 6, 2014